This right will subsist as long as the User Agreement is in force. The User Agreement may be terminated by the Company if:
(i) Optival is in breach of any of the terms, (ii) despite being capable of rectification, Optival fails to rectify such breach within
thirty days of notice served to Optival regarding this, or (iii) at the sole discretion of the Company. On termination of the User
Agreement, Optival is to: (i) immediately stop any further use of the Trademarks; (ii) handover to the Company or its duly
authorized representative’s all dyes, blocks, labels, packaging printed material or the like featuring the Trademark; and (iii) join
the Company in an application to have the entry of Optival as a registered user cancelled at the Trademarks Office and to do
such acts or sign such papers as required; if Optival fails to comply with the requirements, the Company is given full and
irrevocable power of attorney by Optival to do such acts or sign such papers as required on behalf of Optival to effect
cancellation.

Our Company and Optival have agreed that Optival shall pay a license fee of 0.15% (and additional taxes) on total sales per
month of owned and franchised stores with effect from February 1, 2019, for its usage of the Trademark.

Buyback Agreement dated January 25, 2021 entered into between PI Opportunities Fund — I, Lavender Rose Investment
Ltd, Gangadi Madhukar Reddy, Gangadi Investments Private Limited, Agilemed Investments Private Limited and Lone
Furrow Investments Private Limited (together, the “Parties”) (“Buyback Agreement”) as amended by the waiver cum
amendment agreement to the Buyback Agreement dated August 5, 2021 (“Buyback WCA”)

Pursuant to the Buyback Agreement, Gangadi Madhukar Reddy, Gangadi Investments Private Limited, Agilemed Investments
Private Limited and Lone Furrow Investments Private Limited have agreed to provide buy-back rights to PIOF and Lavender
Rose. In the event that a QIPO, strategic sale or third party sale as mentioned in the SHA is not completed by April 10, 2024,
PIOF and Lavender Rose have the right to exercise their buy-back rights.

The Parties have entered into the Buyback WCA. Pursuant to the Buyback WCA, PIOF and Lavender Rose have, inter alia,
waived their right to exercise the investor buy-back option in case the Company does not complete the exit options of QIPO,
strategic sale or third party sale by April 10, 2024, with effect from the date of filing of the draft red herring prospectus. Pursuant
to the Buyback WCA, the Buyback Agreement along with the Buyback WCA shall stand automatically terminated, in its
entirety, upon listing and trading of the Equity Shares of the Company pursuant to an IPO, without any further act or deed
required on the part of any party.

The Buyback WCA will terminate if (i) the initial public offering of the Equity Shares on the Stock Exchanges is not completed
on or prior to the six months from the filing of the draft red herring prospectus or red herring prospectus in connection with the
IPO or any such other timeline as may be mutually agreed amongst the Promoters, PIOF and Lavender Rose or (ii) if the
Company and majority of the Selling Shareholders jointly decide not to undertake the initial public offering.

Letters dated August 6, 2021 acknowledged by Vistra ITCL (India) Limited as the debenture trustee for the debenture
holders, namely, Morning Brook Investment Ltd and Zash Traders respectively, in relation to Pledged Shares ("Pledge
Modification Letters") read with the modification letters dated November 24, 2021 and November 25, 2021 (“Supplemental
Letters")

Pursuant to the Pledge Modification Letters, in respect of 1,676,418 Series B2 CCPS pledged by Lone Furrow Investments
Private Limited in favour of Zash Traders (through Vistra ITCL (India) Limited) (“Pledge A Shares”) (i) the pledge on the
portion of Pledge A Shares, which on conversion to Equity Shares, is proposed to be offered for Sale in the Offer by Lone
Furrow, will be released prior to the date of filing of this Prospectus with the RoC; (ii) the pledge on the remaining Pledge A
Shares i.e., the portion of the Pledge A Shares which neither proposed to be offered in the Offer for Sale by Lone Furrow nor
contributed to minimum promoters’ contribution, will be released on or about the Bid/Offer Closing Date.

Further, pursuant to the Pledge Modification Letter in respect of 1,721,445 Series B1 CCPS pledged by Agilemed Investments
Private Limited in favour of Morning Brook Investment Ltd (through Vistra ITCL (India) Limited) (“Pledge B Shares”), the
pledge on the Pledge B Shares will be released as may be mutually agreed amongst the parties at the time of filing of this
Prospectus, subject to compliance with the terms of the respective debenture documents, the Pledge Modification Letters and
applicable law.

Pursuant to the Pledge Modification Letters, the pledge on the Equity Shares held by the Promoters which will be contributed
towards minimum promoters’ contribution have been released prior to the date of filing of the Draft Red Herring Prospectus.

As per the debenture documents entered into by Lone Furrow read with the Pledge Modification Letter, prior written consent
of the lenders is required to dispose any assets of Lone Furrow, including the shares held by Lone Furrow in the Company.

Pursuant to a letter dated November 24, 2021, Morning Brook Investment Ltd has released the pledge over the Pledge B Shares,
which have since been converted into 8,607,225 Equity Shares pursuant to a resolution passed by the Board dated November
22, 2021. Accordingly, the pledge over 8,607,225 Equity Shares issued upon conversion of 1,721,455 Series B1 CCPS, has
been released.

183
